-- Israel Stocks: Ampal, Camtek, Danya Cebus, Africa-Israel, Xfone
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-01-18T15:55:51Z
-- http://www.bloomberg.com/news/2012-01-18/israel-stocks-ampal-camtek-danya-cebus-africa-israel-xfone.html
Israel ’s  TA-25 Index (TA-25)  declined for
the first time in three days, dropping 0.2 percent to 1,131.3,
at the 4:30 p.m. close in  Tel Aviv . The measure has climbed 4.2
percent this year. Investors traded about 945 million shekels
($248 million) of shares and convertible securities, according
to bourse data.  The following stocks rose or fell today. Symbols are in
parentheses.  Ampal-American Israel (AMPL)  Corp, the owner of a stake
in a company that exports gas from  Egypt  to Israel, advanced 5.2
percent to 1.726 shekels, the highest since Oct. 31. Globes
reported gas supply from Egypt has been restored partially after
flows to Israel were halted on Nov. 28 following an explosion on
the Sinai pipeline network.  Camtek Ltd. (CAMT)  (CAMT IT) slumped the most since Nov. 22,
retreating 4 percent to 8.034 shekels. The maker of automated
optical inspection systems said fourth-quarter revenue would be
$20.5 million to $21 million, or about 5 percent below its
previously issued guidance.  Can Fite Biopharma Ltd. (CFBI)   rose for a second day,
gaining 1 percent to 0.484 shekel. The biopharmaceutical company
said 85 percent of patients in a Phase I/II clinical trial of
its CF102 drug to treat liver cancer reacted positively.  Danya Cebus Ltd. (DNYA)   surged the most since January
2009, soaring 29 percent to 14.98 shekels.  Africa-Israel
Investments Ltd. (AFIL)   offered to buy the 27 percent it
doesn’t already own of the construction services company for
14.50 shekels a share. Africa-Israel climbed 0.9 percent to
14.04 shekels, the highest since Jan. 10.  Prolor Biotech Inc. (PBTH)   gained the third time this
week, rising 4 percent to 24.17 shekels. The biotechnology
company that uses proteins to improve existing treatments said
twice-monthly injections of its modified version of human growth
hormone showed potential to replace daily injections in a pilot
study.       Xfone Inc. (XFN)   jumped to the highest since Dec. 19,
advancing 7.3 percent to 1.75 shekels, the equivalent of 46
cents, after the U.S.-traded shares soared 18 percent to 46
cents yesterday. The provider of long-distance and data services
said it connected its fiber network expanded to include Slaton,
 Texas . The company said yesterday it expects fourth-quarter
FTTP, or Fiber-To-The Premise, revenue to increase 30 percent.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  